Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin adjunctive therapy in adults with drug-susceptible pulmonary tuberculosis
NL-OMON47928Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in pulmonary tuberculosis (TB) comparing Azithromycin + HRZE with Standard of care HRZE (2 arms). Primary endpoint: Systemic inflammation. Started Mar 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON47928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47928.